Methylated circulating tumor DNA (Met-DNA) as an independent prognostic factor in metastatic pancreatic adenocarcinoma (mPAC) patients. - Archive ouverte HAL Access content directly
Conference Papers Year :

Methylated circulating tumor DNA (Met-DNA) as an independent prognostic factor in metastatic pancreatic adenocarcinoma (mPAC) patients.

JOURNAL OF CLINICAL ONCOLOGY Volume: 37 Issue: 15 Supplement: S Meeting Abstract: 4136 Published: MAY 20 2019

, (1) , (2) , (3) , (4) , (5) , (6) , (7) , (1) , (8) , (1)
1
2
3
4
5
6
7
8

Domains

Life Sciences [q-bio]

Valerie TALY  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-02413138

Submitted on : Monday, December 16, 2019-10:01:36 AM

Last modification on : Saturday, October 15, 2022-3:54:06 AM

Not file

Dates and versions

inserm-02413138 , version 1 (16-12-2019)

Identifiers

  • HAL Id : inserm-02413138 , version 1

Cite

D. Pietrasz, Shufang Wang-Renault, Laetitia Dahan, Julien Taieb, Karine Le Malicot, et al.. Methylated circulating tumor DNA (Met-DNA) as an independent prognostic factor in metastatic pancreatic adenocarcinoma (mPAC) patients.. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), May 2019, Chicago, United States. ⟨inserm-02413138⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM CESP UVSQ USPC UNIV-PARIS-SACLAY SORBONNE-UNIVERSITE SU-MEDECINE UNIV-PARIS GS-SANTE-PUBLIQUE
23 View
0 Download

Share

Gmail Facebook Twitter LinkedIn More